138 related articles for article (PubMed ID: 30007629)
1. Genipin-crosslinked carboxymethyl chitosan nanogel for lung-targeted delivery of isoniazid and rifampin.
Wu T; Liao W; Wang W; Zhou J; Tan W; Xiang W; Zhang J; Guo L; Chen T; Ma D; Yu W; Cai X
Carbohydr Polym; 2018 Oct; 197():403-413. PubMed ID: 30007629
[TBL] [Abstract][Full Text] [Related]
2. Lower cytotoxicity, high stability, and long-term antibacterial activity of a poly(methacrylic acid)/isoniazid/rifampin nanogel against multidrug-resistant intestinal Mycobacterium tuberculosis.
Chen T; Li Q; Guo L; Yu L; Li Z; Guo H; Li H; Zhao M; Chen L; Chen X; Zhong Q; Zhou L; Wu T
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():659-65. PubMed ID: 26478357
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Delivery of Isoniazid in Nanogel-Loaded Chitosan Hybrid Microparticles for Inhalation.
Omar SM; Maziad NA; El-Tantawy NM
J Aerosol Med Pulm Drug Deliv; 2019 Apr; 32(2):78-87. PubMed ID: 30526251
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
Hillemann D; Rüsch-Gerdes S; Richter E
J Clin Microbiol; 2007 Aug; 45(8):2635-40. PubMed ID: 17537937
[TBL] [Abstract][Full Text] [Related]
5. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
Aslan G; Tezcan S; Serin MS; Emekdas G
Jpn J Infect Dis; 2008 Jul; 61(4):255-60. PubMed ID: 18653964
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
Robledo J; Mejia GI; Paniagua L; Martin A; Guzmán A
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
[TBL] [Abstract][Full Text] [Related]
7. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
Aslan G; Tezcan S; Emekdaş G
Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
[TBL] [Abstract][Full Text] [Related]
9. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
[TBL] [Abstract][Full Text] [Related]
10. Smartly Engineered PEGylated Di-Block Nanopolymeric Micelles: Duo Delivery of Isoniazid and Rifampicin Against Mycobacterium tuberculosis.
Rani S; Gothwal A; Khan I; Pachouri PK; Bhaskar N; Gupta UD; Chauhan DS; Gupta U
AAPS PharmSciTech; 2018 Oct; 19(7):3237-3248. PubMed ID: 30191379
[TBL] [Abstract][Full Text] [Related]
11. Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.
Grosset J; Truffot-Pernot C; Lacroix C; Ji B
Antimicrob Agents Chemother; 1992 Mar; 36(3):548-51. PubMed ID: 1622164
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model.
Hu Y; Pertinez H; Ortega-Muro F; Alameda-Martin L; Liu Y; Schipani A; Davies G; Coates A
Antimicrob Agents Chemother; 2016 Aug; 60(8):4778-85. PubMed ID: 27216065
[TBL] [Abstract][Full Text] [Related]
14. Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles.
Kumarasingam K; Vincent M; Mane SR; Shunmugam R; Sivakumar S; Uma Devi KR
Int J Mycobacteriol; 2018; 7(1):84-88. PubMed ID: 29516891
[TBL] [Abstract][Full Text] [Related]
15. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
[TBL] [Abstract][Full Text] [Related]
16. Resistance of Mycobacterium tuberculosis isolates in different populations in Greece during 1993-2002.
Kanavaki S; Mantadakis E; Nikolaou S; Papavassiliou A; Karambela S; Anagnostou S; Falagas ME; Samonis G
Int J Tuberc Lung Dis; 2006 May; 10(5):559-64. PubMed ID: 16704040
[TBL] [Abstract][Full Text] [Related]
17. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS
Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies on the influence of dimethylsulfoxide (DMSO) on reversion to sensitivity to isonicotinic acid hydrazide (INH) and rifampicin (RMP) in resistant strains of tubercle bacilli.
Szydłowska T; Pawłowska I
Arch Immunol Ther Exp (Warsz); 1976; 24(4):575-7. PubMed ID: 826230
[TBL] [Abstract][Full Text] [Related]
19. Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.
Coban AY; Cihan CC; Bilgin K; Uzun M; Akgunes A; Cetinkaya E; Durupinar B
Int J Tuberc Lung Dis; 2006 Apr; 10(4):450-3. PubMed ID: 16602412
[TBL] [Abstract][Full Text] [Related]
20. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis.
Foongladda S; Roengsanthia D; Arjrattanakool W; Chuchottaworn C; Chaiprasert A; Franzblau SG
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1118-22. PubMed ID: 12546122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
